GlaxoSmithKline is pulling a longstanding, life-saving asthma inhaler from the market, putting asthmatic children at risk

(NaturalNews) After jacking up the price of inhaler medication by 50 percent over the past decade, British multinational pharmaceutical and biotechnology company…